Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quest Pharmatech Inc (QPT.VN)

Quest Pharmatech Inc (QPT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,920
  • Shares Outstanding, K 169,129
  • Annual Sales, $ 0 K
  • Annual Income, $ -3,018 K
  • 60-Month Beta -0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.27
Trade QPT.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings $-0.01 on 06/28/24
  • Next Earnings Date 09/19/24 [--]
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend 0.055 on 07/21/05
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.015 +133.33%
on 08/28/24
0.035 unch
on 09/19/24
+0.005 (+16.67%)
since 08/19/24
3-Month
0.015 +133.33%
on 08/28/24
0.040 -12.50%
on 07/15/24
+0.010 (+40.00%)
since 06/18/24
52-Week
0.015 +133.33%
on 08/28/24
0.070 -50.00%
on 12/20/23
-0.025 (-41.67%)
since 09/19/23

Most Recent Stories

More News
Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life...

QPT.VN : 0.035 (+40.00%)
Quest Receives Cash Dividend Payment from OncoQuest

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life...

QPT.VN : 0.035 (+40.00%)
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") a Canadian based pharmaceutical company developing products to improve the quality of life...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Provides Corporate Update

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") wishes to provide an update to its June 2 and June 6, 2023 news releases announcing the...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Announces Results from AGM

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 13 2023 annual general meeting of shareholders....

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Provides Product Development Update

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), a Canadian based pharmaceutical company developing products to improve the quality of...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Provides Corporate Update

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") provided the following corporate update today. Grant of Stock Options Quest announces the...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company"), at the request of the TSX Venture Exchange, is providing additional information to...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Provides Corporate Update

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") provided the following corporate update today. OQP Bio Inc. Debentures The Company...

QPT.VN : 0.035 (+40.00%)
Quest PharmaTech Announces Results from AGM

/CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders....

QPT.VN : 0.035 (+40.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing...

See More

Key Turning Points

3rd Resistance Point 0.035
2nd Resistance Point 0.035
1st Resistance Point 0.035
Last Price 0.035
1st Support Level 0.035
2nd Support Level 0.035
3rd Support Level 0.035

See More

52-Week High 0.070
Fibonacci 61.8% 0.049
Fibonacci 50% 0.043
Fibonacci 38.2% 0.036
Last Price 0.035
52-Week Low 0.015

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar